Pharmacogenetic Influence of GST Polymorphisms on Anthracycline-Based Chemotherapy Responses and Toxicity in Breast Cancer Patients: A Multi-Analytical Approach-Reference-Cited by-同舟云学术

Pharmacogenetic Influence of GST Polymorphisms on Anthracycline-Based Chemotherapy Responses and Toxicity in Breast Cancer Patients: A Multi-Analytical Approach

Published:2013-06-28 Issue:6 Volume:17 Page:371-379
ISSN:1177-1062
Container-title:Molecular Diagnosis & Therapy
language:en
Short-container-title:Mol Diagn Ther

Author:

Tulsyan Sonam,Chaturvedi Pankaj,Agarwal Gaurav,Lal Punita,Agrawal Sushma,Mittal Rama Devi,Mittal Balraj

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s40291-013-0045-4.pdf

Reference33 articles.

1. Rodrigues FF, Santos RE, Melo MB, Silva MA, Oliveira AL, Rozenowicz RL, et al. Correlation of polymorphism C3435T of the MDR-1 gene and the response of primary chemotherapy in women with locally advanced breast cancer. Genet Mol Res. 2008;7(1):177–83.

2. Arun BK, Granville LA, Yin G, Middleton LP, Dawood S, Kau SW, et al. Glutathione-S-transferase-pi expression in early breast cancer: association with outcome and response to chemotherapy. Cancer Invest. 2010;28(5):554–9.

3. Huang MY, Wang YH, Chen FM, Lee SC, Fang WY, Cheng TL, et al. Multiple genetic polymorphisms of GSTP1 313AG, MDR1 3435CC, and MTHFR 677CC highly correlated with early relapse of breast cancer patients in Taiwan. Ann Surg Oncol. 2008;15(3):872–80.

4. Hirshfield KM, Rebbeck TR, Levine AJ. Germline mutations and polymorphisms in the origins of cancers in women. J Oncol. 2010. 297671. doi: 10.1155/2010/297671 .

5. Townsend DM, Tew KD. The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene. 2003;22(47):7369–75.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment and Validation of a Prognostic Risk Model Based on Adme-Related Genes in Breast Cancer;2024

2. The mechanisms of multidrug resistance of breast cancer and research progress on related reversal agents;Bioorganic & Medicinal Chemistry;2023-11

3. Recent Advances in Nasopharyngeal Cancer Management: From Diagnosis to Theranostics;Current Pharmacogenomics and Personalized Medicine;2023-04

4. GSTP1 c.313A > G mutation is an independent risk factor for neutropenia hematotoxicity induced by anthracycline-/paclitaxel-based chemotherapy in breast cancer patients;World Journal of Surgical Oncology;2022-06-22

5. GSTP1 Ile105Val and GPX1 Pro198Leu Polymorphisms and Their Association with Response to Radiotherapy in Nasopharyngeal Carcinoma Patients;Eurasian Journal of Medicine and Oncology;2022